Venkatesh, H. S. et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549, 533–537 (2017).
Google Scholar
Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539–545 (2019).
Google Scholar
Venkataramani, V. et al. Glutamatergic synaptic input to glioma cells drives brain tumor progression. Nature 573, 532–538 (2019).
Google Scholar
Balood, M. et al. Nociceptor neurons affect cancer immunosurveillance. Nature 611, 405–412 (2022).
Google Scholar
Hanahan, D. & Monje, M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell 41, 573–580 (2023).
Google Scholar
Shi, D. D. et al. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. Lancet Oncol. 23, e62–e74 (2022).
Google Scholar
Stupp, R. et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. Jama 318, 2306–2316 (2017).
Google Scholar
Hiller, J. G. et al. Preoperative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial. Clin. Cancer Res. 26, 1803–1811 (2020).
Google Scholar
Ayala, G. E. et al. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate 49, 213–223 (2001).
Google Scholar
Ayala, G. E. et al. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin. Cancer Res. 14, 7593–7603 (2008).
Google Scholar
Mauffrey, P. et al. Progenitors from the central nervous system drive neurogenesis in cancer. Nature 569, 672–678 (2019).
Google Scholar
Amit, M. et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578, 449–454 (2020).
Google Scholar
Monje, M. et al. Roadmap for the emerging field of cancer neuroscience. Cell 181, 219–222 (2020).
Google Scholar
Pan, C. & Winkler, F. Insights and opportunities at the crossroads of cancer and neuroscience. Nat. Cell Biol. 24, 1454–1460 (2022).
Google Scholar
Mancusi, R. & Monje, M. The neuroscience of cancer. Nature 618, 467–479 (2023).
Google Scholar
Keough, M. B. & Monje, M. Neural signaling in cancer. Annu. Rev. Neurosci. 45, 199–221 (2022).
Google Scholar
Zahalka, A. H. & Frenette, P. S. Nerves in cancer. Nat. Rev. Cancer 20, 143–157 (2020).
Google Scholar
Varn, F. S. et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185, 2184–2199.e2116 (2022).
Google Scholar
Hoogstrate, Y. et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell 41, 678–692.e677 (2023).
Google Scholar
Liu, J. et al. Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer Cell 42, 1217–1238.e1219 (2024).
Google Scholar
Venkatesh, H. S. et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell 161, 803–816 (2015).
Google Scholar
Park, M. et al. CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits. Neuron 70, 742–757 (2011).
Google Scholar
Jeong, J. et al. Regulation of NLGN3 and the synaptic Rho-GEF signaling pathway by CDK5. J. Neurosci. 43, 7264–7275 (2023).
Google Scholar
Xu, N. et al. Integrated proteogenomic characterization of urothelial carcinoma of the bladder. J. Hematol. Oncol. 15, 76 (2022).
Google Scholar
Pan, Y. et al. NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature 594, 277–282 (2021).
Google Scholar
Taylor, K. R. et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature 623, 366–374 (2023).
Li, Z. et al. NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway. Eur. J. Pharm. 857, 172423 (2019).
Google Scholar
Wei, J. et al. Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway. Acta Pharm. Sin. B 12, 3861–3876 (2022).
Google Scholar
Yun, E. J. et al. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Cell Death Dis. 14, 423 (2023).
Google Scholar
Li, J. et al. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis. J. Exp. Clin. Cancer Res. 43, 28 (2024).
Google Scholar
Wang, J. et al. LINC00665 activating Wnt3a/β-catenin signaling by bond with YBX1 promotes gastric cancer proliferation and metastasis. Cancer Gene Ther. 30, 1530–1542 (2023).
Google Scholar
Stopczynski, R. E. et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Res. 74, 1718–1727 (2014).
Google Scholar
Renz, B. W. et al. β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer. Cancer Cell 34, 863–867 (2018).
Google Scholar
Whiteley, A. E. et al. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science 384, eadh5548 (2024).
Google Scholar
He, S. et al. GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling. Proc. Natl. Acad. Sci. USA 111, E2008–E2017 (2014).
Google Scholar
Ceyhan, G. O. et al. The neurotrophic factor artemin promotes pancreatic cancer invasion. Ann. Surg. 244, 274–281 (2006).
Google Scholar
Le, C. P. et al. Chronic stress in mice remodels lymph vasculature to promote tumor cell dissemination. Nat. Commun. 7, 10634 (2016).
Google Scholar
Creed, S. J. et al. β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res 17, 145 (2015).
Google Scholar
Padmanaban, V. et al. Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis. Nature 633, 207–215 (2024).
Chen, P. et al. Olfactory sensory experience regulates gliomagenesis via neuronal IGF1. Nature 606, 550–556 (2022).
Google Scholar
van Kessel, E. et al. Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma. Neuro Oncol. 24, 1660–1670 (2022).
Google Scholar
Faulkner, S. et al. Tumor neurobiology and the war of nerves in cancer. Cancer Discov. 9, 702–710 (2019).
Google Scholar
Yang, M. W. et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma. Cancer Res. 80, 1991–2003 (2020).
Google Scholar
Zahalka, A. H. et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358, 321–326 (2017).
Google Scholar
Servick, K. War of nerves. Science 365, 1071–1073 (2019).
Google Scholar
Hartmann, D. A. et al. Brain capillary pericytes exert a substantial but slow influence on blood flow. Nat. Neurosci. 24, 633–645 (2021).
Google Scholar
Wälchli, T. et al. Shaping the brain vasculature in development and disease in the single-cell era. Nat. Rev. Neurosci. 24, 271–298 (2023).
Google Scholar
Zhu, P. et al. 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis. Neuron 110, 2268–2282.e2264 (2022).
Google Scholar
Chen, H.-C. et al. Histone serotonylation regulates ependymoma tumorigenesis. Nature 632, 903–910 (2024).
Silbereis, J. C. et al. The cellular and molecular landscapes of the developing human central nervous system. Neuron 89, 248–268 (2016).
Google Scholar
Ohtaka-Maruyama, C. et al. Synaptic transmission from subplate neurons controls radial migration of neocortical neurons. Science 360, 313–317 (2018).
Google Scholar
Ming, G. et al. Electrical activity modulates growth cone guidance by diffusible factors. Neuron 29, 441–452 (2001).
Google Scholar
Venkataramani, V. et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185, 2899–2917.e2831 (2022).
Google Scholar
Zeng, Q. et al. Synaptic proximity enables NMDAR signaling to promote brain metastasis. Nature 573, 526–531 (2019).
Google Scholar
Buckingham, S. C. et al. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med 17, 1269–1274 (2011).
Google Scholar
Campbell, S. L. et al. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. Glia 63, 23–36 (2015).
Google Scholar
Barron, T. et al. GABAergic neuron-to-glioma synapses in diffuse midline gliomas. Nature 639, 1060–1068 (2025).
Li, N. et al. The delta subunit of the GABA(A) receptor is necessary for the GPT2-promoted breast cancer metastasis. Theranostics 13, 1355–1369 (2023).
Google Scholar
Neman, J. et al. Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc. Natl. Acad. Sci. USA 111, 984–989 (2014).
Google Scholar
John Lin, C. C. et al. Identification of diverse astrocyte populations and their malignant analogs. Nat. Neurosci. 20, 396–405 (2017).
Google Scholar
Yu, K. et al. PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis. Nature 578, 166–171 (2020).
Google Scholar
Krishna, S. et al. Glioblastoma remodelling of human neural circuits decreases survival. Nature 617, 599–607 (2023).
Google Scholar
Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93–98 (2015).
Google Scholar
Gritsenko, P. G. et al. p120-catenin-dependent collective brain infiltration by glioma cell networks. Nat. Cell Biol. 22, 97–107 (2020).
Google Scholar
Winkler, F. & Wick, W. Harmful networks in the brain and beyond. Science 359, 1100–1101 (2018).
Google Scholar
Jung, E. et al. Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma. Nat. Commun. 12, 1014 (2021).
Google Scholar
Jung, E. et al. Tweety-homolog 1 drives brain colonization of gliomas. J. Neurosci. 37, 6837–6850 (2017).
Google Scholar
Hausmann, D. et al. Autonomous rhythmic activity in glioma networks drives brain tumor growth. Nature 613, 179–186 (2023).
Google Scholar
Winkler, F. et al. Cancer neuroscience: state of the field, emerging directions. Cell 186, 1689–1707 (2023).
Google Scholar
Hayakawa, Y. et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell 31, 21–34 (2017).
Google Scholar
Ayala, G. Neuroepithelial interactions in cancer. Annu Rev. Pathol. 18, 493–514 (2023).
Google Scholar
Zhi, X. et al. Nociceptive neurons promote gastric tumor progression via a CGRP–RAMP1 axis. Nature 640, 802–810 (2025).
Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T-cells. Cell Rep. 39, 110986 (2022).
Google Scholar
Li, X. et al. Lactate metabolism in human health and disease. Signal Transduct. Target Ther. 7, 305 (2022).
Google Scholar
Torrini, C. et al. Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma. Mol. Cell 82, 3061–3076.e3066 (2022).
Google Scholar
Li, F. et al. Glial metabolic rewiring promotes axon regeneration and functional recovery in the central nervous system. Cell Metab. 32, 767–785.e767 (2020).
Google Scholar
Jia, L. et al. Rheb-regulated mitochondrial pyruvate metabolism of Schwann cells linked to axon stability. Dev. Cell 56, 2980–2994.e2986 (2021).
Google Scholar
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
Google Scholar
Chinchore, Y. et al. Glycolytic reliance promotes anabolism in photoreceptors. Elife 6, e25946 (2017).
Google Scholar
Todorova, V. et al. Deficits in mitochondrial TCA cycle and OXPHOS precede rod photoreceptor degeneration during chronic HIF activation. Mol. Neurodegener. 18, 15 (2023).
Google Scholar
Minhas, P. S. et al. Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies. Science 385, eabm6131 (2024).
Google Scholar
Zhang, X., Liu, Q., Liao, Q. & Zhao, Y. Potential roles of peripheral dopamine in tumor immunity. J. Cancer 8, 2966–2973 (2017).
Google Scholar
Cheng, J. et al. Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs. Drug Resist. Updat 73, 101056 (2024).
Google Scholar
Eisenhofer, G. et al. Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab. 82, 3864–3871 (1997).
Google Scholar
Cervantes-Villagrana, R. D., Albores-García, D., Cervantes-Villagrana, A. R. & García-Acevez, S. J. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct. Target Ther. 5, 99 (2020).
Google Scholar
Saha, B., Mondal, A. C., Basu, S. & Dasgupta, P. S. Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. Int. Immunopharmacol. 1, 1363–1374 (2001).
Google Scholar
Zhou, Y. et al. DRD4 interacts with TGF-β receptors to drive colorectal cancer metastasis independently of dopamine signaling pathway. Adv Sci. 12, 2413953 (2024).
Zhang, W. et al. Injectable and adhesive MgO(2)-potentiated hydrogel with sequential tumor synergistic therapy and osteogenesis for challenging postsurgical osteosarcoma treatment. Biomaterials 315, 122959 (2025).
Google Scholar
Mei, L. et al. Self-propelling intelligent nanomotor: a dual-action photothermal and starvation strategy for targeted deep tumor destruction. Biomaterials 315, 122968 (2025).
Google Scholar
Kong, X. et al. Melatonin: a potential therapeutic option for breast cancer. Trends Endocrinol. Metab. 31, 859–871 (2020).
Google Scholar
Cheng, L. et al. Melatonin regulates cancer migration and stemness and enhances the anti-tumour effect of cisplatin. J. Cell Mol. Med. 27, 2215–2227 (2023).
Google Scholar
Stryjewska, A. et al. Zeb2 regulates cell fate at the exit from epiblast state in mouse embryonic stem cells. Stem Cells 35, 611–625 (2017).
Google Scholar
Srivatsa, S., Parthasarathy, S., Molnár, Z. & Tarabykin, V. Sip1 downstream effector ninein controls neocortical axonal growth, ipsilateral branching, and microtubule growth and stability. Neuron 85, 998–1012 (2015).
Google Scholar
Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29, 212–226 (2019).
Google Scholar
Lin, J. et al. A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis. Elife 12, RP87510 (2023).
Google Scholar
Wiles, E. T. et al. ZEB2 represses the epithelial phenotype and facilitates metastasis in Ewing sarcoma. Genes Cancer 4, 486–500 (2013).
Google Scholar
Zeng, Y. et al. Oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma. Mol. Ther. Nucleic Acids 23, 769–782 (2021).
Google Scholar
Wang, M. et al. Different lineage contexts direct common pro-neural factors to specify distinct retinal cell subtypes. J. Cell Biol. 219, e202003026 (2020).
Google Scholar
Tang, Y. et al. Restoration of visual function and cortical connectivity after ischemic injury through neurod1-mediated gene therapy. Front. Cell Dev. Biol. 9, 720078 (2021).
Google Scholar
Xu, J. et al. Generation of neural organoids for spinal-cord regeneration via the direct reprogramming of human astrocytes. Nat. Biomed. Eng. 7, 253–269 (2023).
Google Scholar
Wang, X. et al. Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion. Cancer Biol. Med. 18, 860–874 (2021).
Google Scholar
Rao, Y. et al. NeuroD1 induces microglial apoptosis and cannot induce microglia-to-neuron cross-lineage reprogramming. Neuron 109, 4094–4108.e4095 (2021).
Google Scholar
Rivetti di Val Cervo, P. et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson’s disease model. Nat. Biotechnol. 35, 444–452 (2017).
Google Scholar
Bocchi, R., Masserdotti, G. & Götz, M. Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches. Neuron 110, 366–393 (2022).
Google Scholar
Jin, M. Z. & Jin, W. L. The updated landscape of tumor microenvironment and drug repurposing. Signal. Transduct. Target Ther. 5, 166 (2020).
Google Scholar
Kim, K. H. et al. Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell 42, 358–377.e358 (2024).
Google Scholar
Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
Google Scholar
Li, Y. T., Yuan, W. Z. & Jin, W. L. Vagus innervation in the gastrointestinal tumor: current understanding and challenges. Biochim. Biophys. Acta Rev. Cancer 1878, 188884 (2023).
Google Scholar
Devi, S. et al. Adrenergic regulation of the vasculature impairs leukocyte interstitial migration and suppresses immune responses. Immunity 54, 1219–1230.e1217 (2021).
Google Scholar
Poller, W. C. et al. Brain motor and fear circuits regulate leukocytes during acute stress. Nature 607, 578–584 (2022).
Google Scholar
Yang, H. et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat. Med. 25, 1428–1441 (2019).
Google Scholar
Xu, X. R. et al. Activation of dopaminergic VTA inputs to the mPFC ameliorates chronic stress-induced breast tumor progression. CNS Neurosci. Ther. 27, 206–219 (2021).
Google Scholar
Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309–322 (2012).
Google Scholar
Giraldo, N. A. et al. The clinical role of the TME in solid cancer. Br. J. Cancer 120, 45–53 (2019).
Google Scholar
Kim, S. K. & Cho, S. W. The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment. Front. Pharm. 13, 868695 (2022).
Google Scholar
Mehrian-Shai, R., Reichardt, J. K. V., Harris, C. C. & Toren, A. The gut-brain axis, paving the way to brain cancer. Trends Cancer 5, 200–207 (2019).
Google Scholar
Leung, E. L.-H. et al. Novel anticancer strategy by targeting the gut microbial neurotransmitter signaling to overcome immunotherapy resistance. Antioxid. Redox Signal. 38, 298–315 (2022).
Google Scholar
Jiang, S. H. et al. Neurotransmitters: emerging targets in cancer. Oncogene 39, 503–515 (2020).
Google Scholar
Khanmammadova, N., Islam, S., Sharma, P. & Amit, M. Neuro-immune interactions and immuno-oncology. Trends Cancer 9, 636–649 (2023).
Google Scholar
Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939–944 (2006).
Google Scholar
Wang, H. et al. Role of the nervous system in cancers: a review. Cell Death Discov. 7, 76 (2021).
Google Scholar
Guo, X. et al. Midkine activation of CD8(+) T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth. Nat. Commun. 11, 2177 (2020).
Google Scholar
Zhang, Z. et al. VLM catecholaminergic neurons control tumor growth by regulating CD8(+) T cells. Proc. Natl. Acad. Sci USA 118, e2103505118 (2021).
Slominski, R. M., Raman, C., Chen, J. Y. & Slominski, A. T. How cancer hijacks the body’s homeostasis through the neuroendocrine system. Trends Neurosci. 46, 263–275 (2023).
Google Scholar
Xu, Y. et al. Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science 377, 1085–1091 (2022).
Google Scholar
Møller, S. H. et al. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging. Cell Metab. 34, 378–395 (2022).
Google Scholar
Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887–904 (2018).
Google Scholar
Pittet, M. J., Michielin, O. & Migliorini, D. Clinical relevance of tumor-associated macrophages. Nat. Rev. Clin. Oncol. 19, 402–421 (2022).
Google Scholar
Kloosterman, D. J. & Akkari, L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell 186, 1627–1651 (2023).
Google Scholar
Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101 (2011).
Google Scholar
Sloan, E. K. et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70, 7042–7052 (2010).
Google Scholar
Partecke, L. I. et al. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade. Pancreatology 16, 423–433 (2016).
Google Scholar
Cheng, Y. et al. Depression-induced neuropeptide Y secretion promotes prostate cancer growth by recruiting myeloid cells. Clin. Cancer Res. 25, 2621–2632 (2019).
Google Scholar
Renz, B. W. et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 8, 1458–1473 (2018).
Google Scholar
Laumont, C. M. & Nelson, B. H. B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell 41, 466–489 (2023).
Google Scholar
Wang, S. S. et al. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. Cell Mol. Immunol. 16, 6–18 (2019).
Google Scholar
Wieland, A. et al. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature 597, 274–278 (2021).
Google Scholar
Michaud, D., Steward, C. R., Mirlekar, B. & Pylayeva-Gupta, Y. Regulatory B cells in cancer. Immunol. Rev. 299, 74–92 (2021).
Google Scholar
Harris, R. J. et al. Tumor-infiltrating B lymphocyte profiling identifies IgG-biased, clonally expanded prognostic phenotypes in triple-negative breast cancer. Cancer Res 81, 4290–4304 (2021).
Google Scholar
Sung, H. Y., Yang, S. D., Ju, W. & Ahn, J. H. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer. Exp. Mol. Med. 49, e335 (2017).
Google Scholar
Kanbara, K. et al. GABA(B) receptor regulates proliferation in the high-grade chondrosarcoma cell line OUMS-27 via apoptotic pathways. BMC Cancer 18, 263 (2018).
Google Scholar
Zhang, B. et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature 599, 471–476 (2021).
Google Scholar
Mohammadpour, H. et al. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell Rep. 37, 109883 (2021).
Google Scholar
Qiao, G. et al. β-Adrenergic signaling blocks murine CD8(+) T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol. Immun. 68, 11–22 (2019).
Google Scholar
Zeng, W. et al. Interactions between central nervous system and peripheral metabolic organs. Sci. China Life Sci. 65, 1929–1958 (2022).
Google Scholar
Ben-Shaanan, T. L. et al. Modulation of anti-tumor immunity by the brain’s reward system. Nat. Commun. 9, 2723 (2018).
Google Scholar
Xu, Q. et al. Multiple cancer cell types release LIF and Gal3 to hijack neural signals. Cell Res. 34, 345–354 (2024).
Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582–598 (2016).
Google Scholar
Martinez-Outschoorn, U. E., Lisanti, M. P. & Sotgia, F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin. Cancer Biol. 25, 47–60 (2014).
Google Scholar
Kobayashi, H. et al. Cancer-associated fibroblasts in gastrointestinal cancer. Nat. Rev. Gastroenterol. Hepatol. 16, 282–295 (2019).
Google Scholar
Oben, J. A. et al. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. Biochem. Biophys. Res. Commun. 302, 685–690 (2003).
Google Scholar
Kim-Fuchs, C. et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40–47 (2014).
Google Scholar
Demir, I. E., Friess, H. & Ceyhan, G. O. Nerve-cancer interactions in the stromal biology of pancreatic cancer. Front. Physiol. 3, 97 (2012).
Google Scholar
Yamazaki, S. et al. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking β₂-adrenergic signaling. Arch. Biochem. Biophys. 557, 18–27 (2014).
Google Scholar
Xue, M. et al. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Nat. Commun. 14, 4600 (2023).
Google Scholar
Li, J., Kang, R. & Tang, D. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Commun. 41, 642–660 (2021).
Google Scholar
Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal. Transduct. Target Ther. 6, 263 (2021).
Google Scholar
Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science 374, 1087–1092 (2021).
Google Scholar
Adler, O. et al. Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2. Nat. Cancer 4, 401–418 (2023).
Google Scholar
Pelly, V. S. et al. Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy. Cancer Discov. 11, 2602–2619 (2021).
Google Scholar
Zhang, J. et al. Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer. Cancer Biol. Ther. 25, 2366451 (2024).
Google Scholar
Xia, Y. et al. Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. Brain Behav. Immun. 81, 111–121 (2019).
Google Scholar
Regalado, C. R. & Balogh, M. MMP9: Link between neuropathy and colorectal cancer? Front. Mol. Biosci. 11, 1451611 (2024).
Google Scholar
An, J. et al. Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling. Oncoimmunology 10, 2004659 (2021).
Google Scholar
Mohammadpour, H. et al. β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J. Clin. Investig. 129, 5537–5552 (2019).
Google Scholar
Lu, J. et al. Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress. Cell Commun. Signal 22, 375 (2024).
Google Scholar
Demir, I. E. et al. Future directions in preclinical and translational cancer neuroscience research. Nat. Cancer 1, 1027–1031 (2021).
Google Scholar
Zhang, Y. et al. Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma. Biomaterials 278, 121163 (2021).
Google Scholar
Zhao, M. et al. Nanocarrier-based drug combination therapy for glioblastoma. Theranostics 10, 1355–1372 (2020).
Google Scholar
Meric-Bernstam, F., Larkin, J., Tabernero, J. & Bonini, C. Enhancing anti-tumor efficacy with immunotherapy combinations. Lancet 397, 1010–1022 (2021).
Google Scholar
Zhao, C. M. et al. Denervation suppresses gastric tumorigenesis. Sci. Transl. Med. 6, 250ra115 (2014).
Google Scholar
Lamkin, D. M. et al. Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. Brain Behav. Immun. 26, 635–641 (2012).
Google Scholar
Lu, R. et al. Neurons generated from carcinoma stem cells support cancer progression. Signal Transduct. Target Ther. 2, 16036 (2017).
Google Scholar
Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).
Google Scholar
Mogavero, M. P. et al. Sleep disorders and cancer: state of the art and future perspectives. Sleep. Med. Rev. 56, 101409 (2021).
Google Scholar
Pitman, A., Suleman, S., Hyde, N. & Hodgkiss, A. Depression and anxiety in patients with cancer. BMJ 361, k1415 (2018).
Google Scholar
Zheng, X. Q., Wu, Y. H., Huang, J. F. & Wu, A. M. Neurophysiological mechanisms of cancer-induced bone pain. J. Adv. Res. 35, 117–127 (2022).
Google Scholar
Yu, S. et al. Depression decreases immunity and PD-L1 inhibitor efficacy via the hypothalamic-pituitary-adrenal (HPA) axis in triple-negative breast cancer. Biochim. Biophys. Acta Mol. Basis Dis. 1871, 167581 (2025).
Google Scholar
Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824–7827 (1982).
Google Scholar
Kress, T. R., Sabò, A. & Amati, B. MYC: connecting selective transcriptional control to global RNA production. Nat. Rev. Cancer 15, 593–607 (2015).
Google Scholar
Dhanasekaran, R. et al. The MYC oncogene—the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19, 23–36 (2022).
Google Scholar
Tang, X. et al. Lipid phosphate phosphatase-2 promotes tumor growth through increased c-Myc expression. Theranostics 12, 5675–5690 (2022).
Google Scholar
Chen, L. et al. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. J. Clin. Investig. 128, 446–462 (2018).
Google Scholar
Chen, J. et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell 29, 1531–1546.e1537 (2022).
Google Scholar
Jiang, B. C. et al. NFAT1 orchestrates spinal microglial transcription and promotes microglial proliferation via c-MYC contributing to nerve injury-induced neuropathic pain. Adv. Sci. 9, e2201300 (2022).
Google Scholar
Belin, S. et al. Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics. Neuron 86, 1000–1014 (2015).
Google Scholar
Ma, J. J. et al. Telomerase reverse transcriptase and p53 regulate mammalian peripheral nervous system and CNS axon regeneration downstream of c-Myc. J. Neurosci. 39, 9107–9118 (2019).
Google Scholar
Blelloch, R., Venere, M., Yen, J. & Ramalho-Santos, M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1, 245–247 (2007).
Google Scholar
Nakagawa, M. et al. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl Acad. Sci. USA 107, 14152–14157 (2010).
Google Scholar
Yang, S. G., Wang, X. W., Qian, C. & Zhou, F. Q. Reprogramming neurons for regeneration: the fountain of youth. Prog. Neurobiol. 214, 102284 (2022).
Google Scholar
Ireland, A. S. et al. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell 38, 60–78.e12 (2020).
Google Scholar
Mullard, A. Climbing cancer’s MYC mountain. Nat. Rev. Drug Discov. 21, 865–867 (2022).
Google Scholar
Sabò, A. et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511, 488–492 (2014).
Google Scholar
Luo, Z. et al. ZFP281 Recruits MYC to active promoters in regulating transcriptional initiation and elongation. Mol Cell Biol. 39, e00329–19 (2019).
Louis, S. F. et al. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc. Natl. Acad. Sci. USA 102, 9613–9618 (2005).
Google Scholar
Moore, A. R., Rosenberg, S. C., McCormick, F. & Malek, S. RAS-targeted therapies: is the undruggable drugged? Nat. Rev. Drug Discov. 19, 533–552 (2020).
Google Scholar
Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297, 474–478 (1982).
Google Scholar
Tanaka, N. et al. Clinical acquired resistance to KRAS(G12C) inhibition through a novel KRAS Switch-II pocket mutation and polyclonal alterations converging on RAS-MAPK reactivation. Cancer Discov. 11, 1913–1922 (2021).
Google Scholar
Pantsar, T. The current understanding of KRAS protein structure and dynamics. Comput. Struct. Biotechnol. J. 18, 189–198 (2020).
Google Scholar
Dombi, E. et al. Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N. Engl. J. Med. 375, 2550–2560 (2016).
Google Scholar
de Blank, P. M. K. et al. MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus. Neuro Oncol. 24, 1845–1856 (2022).
Google Scholar
Costa, R. M. et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415, 526–530 (2002).
Google Scholar
Hall, A. & Lalli, G. Rho and Ras GTPases in axon growth, guidance, and branching. CSH Perspect. Biol. 2, a001818 (2010).
Alcover-Sanchez, B., Garcia-Martin, G., Wandosell, F. & Cubelos, B. R-Ras GTPases signaling role in myelin neurodegenerative diseases. Int. J. Mol. Sci. 21, 5911 (2020).
Sanz-Rodriguez, M. et al. R-Ras1 and R-Ras2 are essential for oligodendrocyte differentiation and survival for correct myelination in the central nervous system. J. Neurosci. 38, 5096–5110 (2018).
Google Scholar
Luo, J. et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210, 157–172 (2013).
Google Scholar
Mitrasinovic, O. M. et al. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system. J. Neurosci. 25, 4442–4451 (2005).
Google Scholar
Wang, Y. et al. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice. Brain Behav. Immun. 106, 49–66 (2022).
Google Scholar
Yu-Ju Wu, C. et al. CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2. Neuro Oncol. 22, 253–266 (2020).
Google Scholar
Liu, D. et al. β2-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene 35, 47–58 (2016).
Google Scholar
Armaiz-Pena, G. N. et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nat. Commun. 4, 1403 (2013).
Google Scholar
Liu, D. et al. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells. Cancer Sci. 111, 4417–4428 (2020).
Google Scholar
Zhang, W. et al. A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers. Front Immunol. 15, 1434027 (2024).
Google Scholar
Newton, R. C. et al. Clinical benefit of INCB7839, a potent and selective ADAM inhibitor, in combination with trastuzumab in patients with metastatic HER2+ breast cancer. J. Clin. Oncol. 28, 3025–3025.
Xiang, Z. et al. Targeting the NOTCH2/ADAM10/TCF7L2 axis-mediated transcriptional regulation of Wnt pathway suppresses tumor growth and enhances chemosensitivity in colorectal cancer. Adv. Sci. 12, 2405758 (2024).
Chen, C. et al. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8(+) T cell exhaustion and anti-PD-1 resistance. Cell Rep. Med. 5, 101686 (2024).
Google Scholar
Johnson, D. A. et al. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res. 67, 2701–2711 (2007).
Google Scholar
Christie, K. J. et al. Enhancing adult nerve regeneration through the knockdown of retinoblastoma protein. Nat. Commun. 5, 3670 (2014).
Google Scholar
Ajioka, I. et al. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131, 378–390 (2007).
Google Scholar
Jansen, R. W. et al. Magnetic resonance imaging can reliably differentiate optic nerve inflammation from tumor invasion in retinoblastoma with orbital cellulitis. Ophthalmology 129, 1275–1286 (2022).
Google Scholar
Kaliki, S. et al. Defining high-risk retinoblastoma: a multicenter global survey. JAMA Ophthalmol. 140, 30–36 (2022).
Google Scholar
House, R. R. J. et al. NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. Mol. Metab. 80, 101876 (2024).
Google Scholar
Li, W. et al. Nuclear localization of mitochondrial TCA cycle enzymes modulates pluripotency via histone acetylation. Nat. Commun. 13, 7414 (2022).
Google Scholar
Ghosh, M. et al. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell 39, 494–508.e495 (2021).
Google Scholar
Hu, J. et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J. Hematol. Oncol. 14, 157 (2021).
Google Scholar
Liu, F. et al. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal Transduct. Target Ther. 6, 55 (2021).
Google Scholar
Lou, J. et al. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit gliomagenesis. Mol. Cancer 19, 138 (2020).
Google Scholar
Chen, J., Tan, Q., Yang, Z. & Jin, Y. Engineered extracellular vesicles: potentials in cancer combination therapy. J. Nanobiotechnol. 20, 132 (2022).
Google Scholar
Gupta, R., Ambasta, R. K. & Pravir, K. Autophagy and apoptosis cascade: which is more prominent in neuronal death? Cell Mol. Life Sci. 78, 8001–8047 (2021).
Google Scholar
Zhou, Z. et al. Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis. J. Transl. Med. 20, 262 (2022).
Google Scholar
Hara, M. R. et al. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. Nature 477, 349–353 (2011).
Google Scholar
Ge, W. et al. In vivo evaluation of guide-free Cas9-induced safety risks in a pig model. Signal Transduct. Target Ther. 9, 184 (2024).
Google Scholar
Li, P. et al. Versatile and efficient mammalian genome editing with type I-C CRISPR system of Desulfovibrio vulgaris. Sci. China Life Sci. 67, 2471–2487 (2024).
Wang, D., Liu, B. & Zhang, Z. Accelerating the understanding of cancer biology through the lens of genomics. Cell 186, 1755–1771 (2023).
Google Scholar
Ignatiadis, M., Sledge, G. W. & Jeffrey, S. S. Liquid biopsy enters the clinic—implementation issues and future challenges. Nat. Rev. Clin. Oncol. 18, 297–312 (2021).
Google Scholar
Trivedi, R. & Bhat, K. P. Liquid biopsy: creating opportunities in brain space. Br. J. Cancer 129, 1727–1746 (2023).
Google Scholar
Esteve-Puig, R., Bueno-Costa, A. & Esteller, M. Writers, readers and erasers of RNA modifications in cancer. Cancer Lett. 474, 127–137 (2020).
Google Scholar
Sun, X. et al. BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. Nature 613, 195–202 (2023).
Google Scholar
Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187–1200 (2017).
Google Scholar
Gojo, J. et al. Single-cell RNA-Seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma. Cancer Cell 38, 44–59.e49 (2020).
Google Scholar
Takahashi, N. et al. Cancer cells co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance. Cancer Cell 33, 985–1003.e1007 (2018).
Google Scholar
Li, W., Deng, X. & Chen, J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin. Cancer Biol. 86, 664–677 (2022).
Google Scholar
Fabbri, L., Chakraborty, A., Robert, C. & Vagner, S. The plasticity of mRNA translation during cancer progression and therapy resistance. Nat. Rev. Cancer 21, 558–577 (2021).
Google Scholar
Culjkovic-Kraljacic, B. & Borden, K. L. Aiding and abetting cancer: mRNA export and the nuclear pore. Trends Cell Biol. 23, 328–335 (2013).
Google Scholar
Bartok, O. et al. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 590, 332–337 (2021).
Google Scholar
Su, P. et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res. 80, 1438–1450 (2020).
Google Scholar
Cerezo, M. et al. Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma. Nat. Med. 24, 1877–1886 (2018).
Google Scholar
Xu, Y. et al. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat. Med. 25, 301–311 (2019).
Google Scholar
Juneja, V. R. et al. PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J. Exp. Med. 214, 895–904 (2017).
Google Scholar
Oh, S. A. et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat. Cancer 1, 681–691 (2020).
Google Scholar
Yin, Y. et al. Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages. Adv. Sci. 9, 2102620 (2022).
Google Scholar
Zhao, Z. et al. Immune checkpoint inhibitors and neurotoxicity. Curr. Neuropharmacol. 19, 1246–1263 (2021).
Google Scholar
Lopes, S. et al. Central nervous system complications of immune checkpoint inhibitors: a comprehensive review. Crit. Rev. Oncol. Hematol. 206, 104595 (2024).
Google Scholar
Han, J. et al. Suppression of KDM5C mitigates the symptoms of Alzheimer’s disease by up-regulating BDNF expression. Neurochem. Int. 186, 105975 (2025).
Google Scholar
Ell, M. A., Schiele, M. A., Iovino, N. & Domschke, K. Epigenetics of fear, anxiety and stress – focus on histone modifications. Curr. Neuropharmacol. 22, 843–865 (2024).
Google Scholar
Heery, R., Finn, S. P., Cuffe, S. D. & Gray, S. G. Long non-coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells. Cancers. 9, 38 (2017).
Boccaletto, P. et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 50, D231–d235 (2022).
Google Scholar
Dai, L. et al. Systematic characterization and biological functions of non-coding RNAs in glioblastoma. Cell Prolif. 56, e13375 (2023).
Google Scholar
Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16, 203–222 (2017).
Google Scholar
Chen, X. et al. TDP-43 regulates cancer-associated microRNAs. Protein Cell 9, 848–866 (2018).
Google Scholar
Ke, H. et al. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3. Proc. Natl. Acad. Sci. USA 115, E3426–e3435 (2018).
Google Scholar
Gao, X. et al. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy. Adv. Mater. 33, e2006116 (2021).
Google Scholar
Maleszewska, M. et al. Sequential changes in histone modifications shape transcriptional responses underlying microglia polarization by glioma. Glia 69, 109–123 (2021).
Google Scholar
Liu, M. et al. Role of non-coding RNAs in axon regeneration after peripheral nerve injury. Int. J. Biol. Sci. 18, 3435–3446 (2022).
Google Scholar
Kopp, F. & Mendell, J. T. Functional classification and experimental dissection of long noncoding RNAs. Cell 172, 393–407 (2018).
Google Scholar
Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 41, 109–120 (2021).
Google Scholar
McCabe, E. M. & Rasmussen, T. P. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin. Cancer Biol. 75, 38–48 (2021).
Google Scholar
Winkler, L. et al. Functional elements of the cis-regulatory lincRNA-p21. Cell Rep. 39, 110687 (2022).
Google Scholar
Huang, J. et al. m(6)A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation. Cell Rep. 41, 111693 (2022).
Google Scholar
Wei, M. et al. Axon-enriched lincRNA ALAE is required for axon elongation via regulation of local mRNA translation. Cell Rep. 35, 109053 (2021).
Google Scholar
Wang, E. et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell 35, 369–384.e367 (2019).
Google Scholar
Qin, H. et al. RNA-binding proteins in tumor progression. J. Hematol. Oncol. 13, 90 (2020).
Google Scholar
Jiang, X. et al. EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2/c-Myc/LDHA signaling. Cancer Res. 82, 831–845 (2022).
Google Scholar
Huang, X. et al. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer. J. Hematol. Oncol. 11, 88 (2018).
Google Scholar
Ding, W. B. et al. HBV/pregenomic RNA increases the stemness and promotes the development of HBV-related HCC through reciprocal regulation with insulin-like growth factor 2 mRNA-binding protein 3. Hepatology 74, 1480–1495 (2021).
Google Scholar
Pan, Z. et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol. Cancer 21, 16 (2022).
Google Scholar
Zhao, B. et al. circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p. Cell Death Dis. 13, 1030 (2022).
Google Scholar
Yao, B. et al. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA. Mol. Cancer 21, 140 (2022).
Google Scholar
Ravanidis, S., Kattan, F. G. & Doxakis, E. Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors. Int. J. Mol. Sci. 19, 2280 (2018).
Kim, J. H. et al. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity. Nat. Commun. 12, 5551 (2021).
Google Scholar
Monday, H. R. et al. Presynaptic FMRP and local protein synthesis support structural and functional plasticity of glutamatergic axon terminals. Neuron 110, 2588–2606.e2586 (2022).
Google Scholar
Zeng, Q. et al. Aberrant hyperexpression of the RNA-binding protein FMRP in tumors mediates immune evasion. Science 378, eabl7207 (2022).
Google Scholar
Kosti, A. et al. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation. Genome Biol. 21, 195 (2020).
Google Scholar
Xu, Y. et al. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell 184, 5215–5229.e5217 (2021).
Google Scholar
Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469–474 (2018).
Google Scholar
Shi, H. et al. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature 563, 249–253 (2018).
Google Scholar
Worpenberg, L. et al. Ythdf is a N6-methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila. EMBO J. 40, e104975 (2021).
Google Scholar
Yu, J. et al. Dynamic m6A modification regulates local translation of mRNA in axons. Nucleic Acids Res. 46, 1412–1423 (2018).
Google Scholar
Cong, P. et al. Identification of the role and clinical prognostic value of target genes of m6A RNA methylation regulators in glioma. Front. Cell Dev. Biol. 9, 709022 (2021).
Google Scholar
Clark, K. D., Lee, C., Gillette, R. & Sweedler, J. V. Characterization of neuronal RNA modifications during non-associative learning in aplysia reveals key roles for tRNAs in behavioral sensitization. ACS Cent. Sci. 7, 1183–1190 (2021).
Google Scholar
Puhl, D. L. et al. Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications. Acta Biomater. 155, 370–385 (2023).
Google Scholar
Sapiro, A. L. et al. Illuminating spatial A-to-I RNA editing signatures within the Drosophila brain. Proc. Natl. Acad. Sci. USA 116, 2318–2327 (2019).
Google Scholar
Urnov, F. D. et al. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet 11, 636–646 (2010).
Google Scholar
Hoban, M. D. et al. CRISPR/Cas9-mediated correction of the sickle mutation in human CD34+ cells. Mol. Ther. 24, 1561–1569 (2016).
Google Scholar
Bjurström, C. F. et al. Reactivating Fetal hemoglobin expression in human adult erythroblasts through BCL11A knockdown using targeted endonucleases. Mol. Ther. Nucleic Acids 5, e351 (2016).
Google Scholar
Peterson, C. W. et al. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates. Blood 127, 2416–2426 (2016).
Google Scholar
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Google Scholar
Miyoshi, N. et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633–638 (2011).
Google Scholar
Polo, J. M. et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617–1632 (2012).
Google Scholar
Katti, A. et al. CRISPR in cancer biology and therapy. Nat. Rev. Cancer 22, 259–279 (2022).
Google Scholar
Winkle, M., El-Daly, S. M., Fabbri, M. & Calin, G. A. Noncoding RNA therapeutics—challenges and potential solutions. Nat. Rev. Drug Discov. 20, 629–651 (2021).
Google Scholar
Sahin, U. & Türeci, Ö. Personalized vaccines for cancer immunotherapy. Science 359, 1355–1360 (2018).
Google Scholar
Vormehr, M., Türeci, Ö. & Sahin, U. Harnessing tumor mutations for truly individualized cancer vaccines. Annu Rev. Med 70, 395–407 (2019).
Google Scholar
Ren, F. et al. Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses. Nat. Biomed. Eng. 8, 726–739 (2023).
Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).
Google Scholar
Boczkowski, D., Nair, S. K., Snyder, D. & Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465–472 (1996).
Google Scholar
Kallen, K. J. & Theß, A. A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs. Ther. Adv. Vaccines 2, 10–31 (2014).
Google Scholar
Heine, A., Juranek, S. & Brossart, P. Clinical and immunological effects of mRNA vaccines in malignant diseases. Mol. Cancer 20, 52 (2021).
Google Scholar
Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817–838 (2021).
Google Scholar
Lim, M., Xia, Y., Bettegowda, C. & Weller, M. Current state of immunotherapy for glioblastoma. Nat. Rev. Clin. Oncol. 15, 422–442 (2018).
Google Scholar
Vik-Mo, E. O. et al. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol. Immun. 62, 1499–1509 (2013).
Google Scholar
Beck, J. D. et al. mRNA therapeutics in cancer immunotherapy. Mol. Cancer 20, 69 (2021).
Google Scholar
Yang, J. et al. Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy. Mol. Ther. Nucleic Acids 30, 184–197 (2022).
Google Scholar
Niu, D., Wu, Y. & Lian, J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct. Target Ther. 8, 341 (2023).
Google Scholar
Nishimura, K. et al. Antibody-dependent cellular cytotoxicity of iPS cell-derived natural killer T cells by Anti-GD2 mAb for neuroblastoma. Cancer Sci. 116, 884–896 (2025).
Google Scholar
Kushner, B. H. et al. A phase II trial of Naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission. Clin. Cancer Res. 31, 1877–1884 (2025).
Li, Y. et al. Using mpMRI, PSMA, and GRPR PET to assess focal therapy eligibility and plan treatment in biopsy-proven low-/intermediate-risk prostate cancer: a whole-mount pathology-based study. Clin. Nucl. Med. 50, 410–418 (2025).
Google Scholar
Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599–620 (2021).
Google Scholar
Lee, H.-G., Wheeler, M. A. & Quintana, F. J. Function and therapeutic value of astrocytes in neurological diseases. Nat. Rev. Drug Discov. 21, 339–358 (2022).
Google Scholar
Deng, T. et al. Advances in mRNA nanomedicines for malignant brain tumor therapy. Smart Mater. Med. 4, 257–265 (2023).
Google Scholar
Zhu, Y., Zhu, L., Wang, X. & Jin, H. RNA-based therapeutics: an overview and prospectus. Cell Death Dis. 13, 644 (2022).
Google Scholar
Zamecnik, P. C. & Stephenson, M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75, 280–284 (1978).
Google Scholar
Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265–280 (2022).
Google Scholar
Teplyuk, N. M. et al. Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic. EMBO Mol. Med. 8, 268–287 (2016).
Google Scholar
Ruan, W. et al. Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy. J. Control Release 351, 739–751 (2022).
Google Scholar
Wu, T., Liu, Y., Cao, Y. & Liu, Z. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma. Adv. Mater. 34, e2110364 (2022).
Google Scholar
Su, J. et al. TfR aptamer enhanced blood-brain barrier penetration of biomimetic nanocomplexes for intracellular transglutaminase 2 imaging and silencing in glioma. Small 18, e2203448 (2022).
Google Scholar
Zhang, Q. et al. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma. Sci. Transl. Med. 15, eadd8280 (2023).
Google Scholar
Katsushima, K. et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat. Commun. 7, 13616 (2016).
Google Scholar
Melnick, K. et al. Contemporary RNA therapeutics for glioblastoma. Neuromol. Med. 24, 8–12 (2022).
Google Scholar
Sood, A. K. et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J. Clin. Investig. 120, 1515–1523 (2010).
Google Scholar
Taddei, M. L., Giannoni, E., Fiaschi, T. & Chiarugi, P. Anoikis: an emerging hallmark in health and diseases. J. Pathol. 226, 380–393 (2012).
Google Scholar
Groc, L. & Choquet, D. Linking glutamate receptor movements and synapse function. Science 368, eaay4631 (2020).
Google Scholar
Blanquie, O. & Bradke, F. Cytoskeleton dynamics in axon regeneration. Curr. Opin. Neurobiol. 51, 60–69 (2018).
Google Scholar
Ljubojevic, N., Henderson, J. M. & Zurzolo, C. The ways of actin: why tunneling nanotubes are unique cell protrusions. Trends Cell Biol. 31, 130–142 (2021).
Google Scholar
Dahlstroem, C., Paraschiakos, T., Sun, H. & Windhorst, S. Cryo-EM structures of actin binding proteins as tool for drug discovery. Biochem. Pharm. 214, 115680 (2023).
Google Scholar
Jung, E. et al. Neuronal signatures in cancer. Int. J. Cancer 147, 3281–3291 (2020).
Google Scholar
Zhu, Y. et al. MLK3 is associated with poor prognosis in patients with glioblastomas and actin cytoskeleton remodeling in glioblastoma cells. Front. Oncol. 10, 600762 (2020).
Google Scholar
Welsch, T. et al. Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization. Cancer Lett. 255, 205–218 (2007).
Google Scholar
Koyuncu, S. et al. Rewiring of the ubiquitinated proteome determines ageing in C. elegans. Nature 596, 285–290 (2021).
Google Scholar
Ru, Q. et al. TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain. J. Clin. Invest. 132, e158545 (2022).
Opazo, P. et al. CaMKII triggers the diffusional trapping of surface AMPARs through phosphorylation of stargazin. Neuron 67, 239–252 (2010).
Google Scholar
Hevia, L. G. & Fanarraga, M. L. Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment. J. Nanobiotechnol. 18, 181 (2020).
Google Scholar
Vaughan, S. & Dawe, H. R. Common themes in centriole and centrosome movements. Trends Cell Biol. 21, 57–66 (2011).
Google Scholar
Kapitein, L. C. & Hoogenraad, C. C. Building the neuronal microtubule cytoskeleton. Neuron 87, 492–506 (2015).
Google Scholar
He, Q. et al. Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization. J. Exp. Clin. Cancer Res. 44, 55 (2025).
Google Scholar
Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253–265 (2004).
Google Scholar
Ishiwata, T., Matsuda, Y. & Naito, Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J. Gastroenterol. 17, 409–418 (2011).
Google Scholar
Calderaro, J. et al. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma. J. Hepatol. 77, 1586–1597 (2022).
Google Scholar
Yang, J. et al. Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse. Nat. Neurosci. 14, 324–330 (2011).
Google Scholar
Moss, J. et al. Fine processes of Nestin-GFP-positive radial glia-like stem cells in the adult dentate gyrus ensheathe local synapses and vasculature. Proc. Natl. Acad. Sci. USA 113, E2536–E2545 (2016).
Google Scholar
Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol. Life Sci. 68, 3033–3046 (2011).
Google Scholar
Fan, Y. et al. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Mol. Cancer 20, 25 (2021).
Google Scholar
Zhang, N. et al. Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells. Cancer Lett. 520, 400–408 (2021).
Google Scholar
Triolo, D. et al. Vimentin regulates peripheral nerve myelination. Development 139, 1359–1367 (2012).
Google Scholar
Yang, D. et al. Axon-like protrusions promote small cell lung cancer migration and metastasis. Elife 8, e50616 (2019).
Venkataramani, V. et al. Disconnecting multicellular networks in brain tumours. Nat. Rev. Cancer 22, 481–491 (2022).
Google Scholar
Cao, Y. Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells. Cell Biosci. 7, 61 (2017).
Google Scholar
Murphy, S. F. et al. Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide. Cancer Res. 76, 139–149 (2016).
Google Scholar
Chen, Q. et al. Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533, 493–498 (2016).
Google Scholar
Grossman, S. A. et al. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J. Clin. Oncol. 27, 4155–4161 (2009).
Google Scholar
Shram, M. J. et al. The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users. Transl. Psychiatry 13, 192 (2023).
Google Scholar
Krishnan, N. et al. A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering. Nat. Nanotechnol. 19, 345–353 (2024).
Google Scholar
Sun, C. et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat. Commun. 14, 2692 (2023).
Google Scholar
Toi, P. T. et al. In vivo direct imaging of neuronal activity at high temporospatial resolution. Science 378, 160–168 (2022).
Google Scholar
Hamada, S. et al. An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping. Commun. Biol. 4, 461 (2021).
Google Scholar
Zhao, Z. et al. Two-photon synthetic aperture microscopy for minimally invasive fast 3D imaging of native subcellular behaviors in deep tissue. Cell 186, 2475–2491.e2422 (2023).
Google Scholar
Liu, R. et al. From 2D to 3D co-culture systems: a review of co-culture models to study the neural cells interaction. Int. J. Mol. Sci. 23, 13116 (2022).
Google Scholar
Lu, T. et al. Decoding transcriptional identity in developing human sensory neurons and organoid modeling. Cell 187, 7374–7393.e7328 (2024).
Google Scholar
Elemento, O., Leslie, C., Lundin, J. & Tourassi, G. Artificial intelligence in cancer research, diagnosis and therapy. Nat. Rev. Cancer 21, 747–752 (2021).
Google Scholar
Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood–brain barrier. Nat. Rev. Drug Discov. 20, 362–383 (2021).
Google Scholar
Ma, F. et al. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci. Adv. 6, eabb4429 (2020).
Google Scholar
Derakhshan, A., Chen, Z. & Van Waes, C. Therapeutic small molecules target inhibitor of apoptosis proteins in cancers with deregulation of extrinsic and intrinsic cell death pathways. Clin. Cancer Res. 23, 1379–1387 (2017).
Google Scholar
Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17, 395–417 (2020).
Google Scholar
Morana, O., Wood, W. & Gregory, C. D. The apoptosis paradox in cancer. Int. J. Mol. Sci. 23, 1328 (2022).
Xu, D. et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174, 1477–1491.e1419 (2018).
Google Scholar
Park, G. et al. Caspase activation and caspase-mediated cleavage of app is associated with amyloid β-protein-induced synapse loss in Alzheimer’s disease. Cell Rep. 31, 107839 (2020).
Google Scholar
Roberts, S. L. et al. Bim contributes to the progression of Huntington’s disease-associated phenotypes. Hum. Mol. Genet 29, 216–227 (2020).
Google Scholar
Han, X. et al. Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson’s disease via promoting PLIN4 degradation. Redox Biol. 52, 102308 (2022).
Google Scholar
Gong, Y. et al. The role of necroptosis in cancer biology and therapy. Mol. Cancer 18, 100 (2019).
Google Scholar
Yang, T. et al. Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis. Cell Rep. 42, 113377 (2023).
Google Scholar
Vucur, M. et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56, 1578–1595.e1578 (2023).
Google Scholar
Mitroshina, E. V., Saviuk, M. & Vedunova, M. V. Necroptosis in CNS diseases: focus on astrocytes. Front. Aging Neurosci. 14, 1016053 (2022).
Google Scholar
Oñate, M. et al. The necroptosis machinery mediates axonal degeneration in a model of Parkinson’s disease. Cell Death Differ. 27, 1169–1185 (2020).
Google Scholar
Wang, Y. et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354, aad6872 (2016).
Zhu, H. et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol. Cancer 19, 49 (2020).
Google Scholar
Ghonim, M. A. et al. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J. Immunother. Cancer 9, e001643 (2021).
Fricker, M. et al. Neuronal cell death. Physiol. Rev. 98, 813–880 (2018).
Google Scholar
Petrelli, F. et al. Poly(ADP-ribose) polymerase is not involved in the neuroprotection exerted by azithromycin against ischemic stroke in mice. Eur. J. Pharm. 791, 518–522 (2016).
Google Scholar
Park, H. et al. PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s disease. Cell 185, 1943–1959.e1921 (2022).
Google Scholar
Mou, Y. et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12, 34 (2019).
Google Scholar
Yang, M. et al. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. J. Hepatol. 76, 1138–1150 (2022).
Google Scholar
Zhang, Y. et al. Loss of COPZ1 induces NCOA4-mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene 40, 1425–1439 (2021).
Google Scholar
Yee, P. P. et al. Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat. Commun. 11, 5424 (2020).
Google Scholar
Moujalled, D., Strasser, A. & Liddell, J. R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 28, 2029–2044 (2021).
Google Scholar
Rao, Z. et al. Pyroptosis in inflammatory diseases and cancer. Theranostics 12, 4310–4329 (2022).
Google Scholar
Wu, J., Wang, L. & Xu, J. The role of pyroptosis in modulating the tumor immune microenvironment. Biomark. Res 10, 45 (2022).
Google Scholar
Wang, B. et al. GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson’s disease. Acta Pharm. Sin. B 13, 2663–2679 (2023).
Google Scholar
Moonen, S. et al. Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 145, 175–195 (2023).
Google Scholar
Tang, D. et al. The molecular machinery of regulated cell death. Cell Res. 29, 347–364 (2019).
Google Scholar
Jiang, X. et al. A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell Discov. 9, 7 (2023).
Google Scholar
Xiang, H. et al. Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharm. Sin. B 10, 569–581 (2020).
Google Scholar
Liu, X., Zhuang, L. & Gan, B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 34, 327–337 (2023).
Xie, J., Yang, Y., Gao, Y. & He, J. Cuproptosis: mechanisms and links with cancers. Mol. Cancer 22, 46 (2023).
Google Scholar
Qin, Y. et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol. Cancer 22, 59 (2023).
Google Scholar
Huang, M., Zhang, Y. & Liu, X. The mechanism of cuproptosis in Parkinson’s disease. Ageing Res. Rev. 95, 102214 (2024).
Google Scholar
Song, J. et al. Cell-in-cell-mediated entosis reveals a progressive mechanism in pancreatic cancer. Gastroenterology 165, 1505–1521.e1520 (2023).
Google Scholar
Erpenbeck, L. & Schön, M. P. Neutrophil extracellular traps: protagonists of cancer progression? Oncogene 36, 2483–2490 (2017).
Google Scholar
Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56, 2755–2772.e2758 (2023).
Google Scholar
Pietronigro, E. C., Della Bianca, V., Zenaro, E. & Constantin, G. NETosis in Alzheimer’s disease. Front Immunol. 8, 211 (2017).
Google Scholar
Qiao, G. et al. Adrenergic stress regulates the exhausted phenotype of T cells in the tumor microenvironment. Trends Neurosci. 204, 165.136–165.136 (2020).
Cosentino, M. et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109, 632–642 (2007).
Google Scholar
Teratani, T. et al. The liver–brain–gut neural arc maintains the Treg cell niche in the gut. Nature 585, 591–596 (2020).
Google Scholar
Zheng, C. et al. Tumor-specific cholinergic CD4(+) T lymphocytes guide immunosurveillance of hepatocellular carcinoma. Nat Cancer. 4, 1437–1454 (2023).
Wang, Y. N. et al. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response. J. Immunother Cancer 11, e007253 (2023).
Li, J. J. et al. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nat. Commun. 14, 6690 (2023).
Google Scholar
Xu, Z. et al. Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines. Biochem. Pharm. 215, 115746 (2023).
Google Scholar
Hou, F. J. et al. Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells. Onco Targets Ther. 12, 6685–6697 (2019).
Google Scholar
Li, J. et al. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer-associated fibroblasts. J. Transl. Med. 21, 248 (2023).
Google Scholar
Fan, J. H. et al. Integrating network pharmacology deciphers the action mechanism of Zuojin capsule in suppressing colorectal cancer. Phytomedicine 96, 153881 (2022).
Google Scholar
Sun, Y. et al. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK-mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT). Phytomedicine 63, 153015 (2019).
Google Scholar
Yousef, E. H., Abo El-Magd, N. F. & El Gayar, A. M. Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7. Life Sci. 324, 121735 (2023).
Google Scholar
Lerro, C. C. et al. Pesticide exposure and incident thyroid cancer among male pesticide applicators in Agricultural Health Study. Environ. Int. 146, 106187 (2021).
Google Scholar
Hu, H. J. et al. Blockade of the forward Na(+) /Ca(2+) exchanger suppresses the growth of glioblastoma cells through Ca(2+) -mediated cell death. Br. J. Pharm. 176, 2691–2707 (2019).
Google Scholar
Liu, Z., Cheng, Q., Ma, X. & Song, M. Suppressing effect of Na(+)/Ca(2+) exchanger (NCX) inhibitors on the growth of melanoma cells. Int. J. Mol. Sci. 23, 901 (2022).
Ahmed, E. A., Alkuwayti, M. A. & Ibrahim, H. M. Atropine is a suppressor of epithelial-mesenchymal transition (EMT) that reduces stemness in drug-resistant breast cancer cells. Int. J. Mol. Sci. 23, 9849 (2022).
Cui, X., Wang, Q., Liu, X. & Kang, C. Levetiracetam: a potent sword against microglia polarization in gliomas. Clin. Cancer Res. 30, 1073–1075 (2024).
Google Scholar
Lv, S. et al. Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer. Cell Death Dis. 13, 754 (2022).
Google Scholar
Zhang, C. et al. Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma. Cell Metab. 36, 778–792.e710 (2024).
Google Scholar
Li, F. et al. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nat. Cancer 5, 131–146 (2024).
Google Scholar
Zhang, C. et al. Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity. J. Exp. Med. 219, e20220541 (2022).
Google Scholar
Ali, O. M., Alotaibi, M. T., Zaki, Y. H. & Amer, H. H. Design, synthesis, and spectroscopic studies of some new α-aminophosphonate analogues derived from 4-hydroxybenzaldehyde with special reference to anticancer activity. Drug Des. Dev Ther. 16, 2589–2599 (2022).
Google Scholar
Jamwal, A. et al. Glabridin plays dual action to intensify anti-metastatic potential of paclitaxel via impeding CYP2C8 in liver and CYP2J2/EETs in tumor of an orthotopic mouse model of breast cancer. Chem. Biol. Interact. 382, 110605 (2023).
Google Scholar
Jeong, J. H. et al. Tumor-derived OBP2A promotes prostate cancer castration resistance. J. Exp. Med. 220, e20211546 (2023).
Google Scholar
Zamora-Sánchez, C. J., Bello-Alvarez, C., Rodríguez-Dorantes, M. & Camacho-Arroyo, I. Allopregnanolone promotes migration and invasion of human glioblastoma cells through the protein tyrosine kinase c-Src activation. Int J. Mol. Sci. 23, 4996 (2022).
Google Scholar
Drljača, J. et al. Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line. CNS Neurosci. Ther. 28, 1447–1457 (2022).
Google Scholar
Wen, X. et al. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics. Theranostics 12, 422–433 (2022).
Google Scholar
Yuan, D. et al. NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages. Proc. Natl. Acad. Sci. USA 120, e2302126120 (2023).
Google Scholar
Vicente-Ruiz, S. et al. Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer. Biomaterials 301, 122280 (2023).
Google Scholar
Chida, K. et al. The role of lidocaine in cancer progression and patient survival. Pharm. Ther. 259, 108654 (2024).
Google Scholar
Cao, L. Q. et al. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth. Mol. Cancer 18, 148 (2019).
Google Scholar
Simeoli, R. et al. Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma. Nat. Commun. 8, 1778 (2017).
Google Scholar
Liu, X. et al. A functionalized collagen-I scaffold delivers microRNA 21-loaded exosomes for spinal cord injury repair. Acta Biomater. 154, 385–400 (2022).
Google Scholar
Liu, Y. et al. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Mol. Cancer 16, 53 (2017).
Google Scholar
Mak, H. K. et al. MicroRNA-19a-PTEN axis is involved in the developmental decline of axon regenerative capacity in retinal ganglion cells. Mol. Ther. Nucleic Acids 21, 251–263 (2020).
Google Scholar
Liu, M. et al. Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology 160, 1771–1783.e1771 (2021).
Google Scholar
Abyadeh, M. et al. Key genes and biochemical networks in various brain regions affected in Alzheimer’s disease. Cells 11, 987 (2022).
Google Scholar
Dou, R. et al. EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin. Transl. Med. 11, e595 (2021).
Google Scholar
Chen, K. et al. Hypoxic pancreatic cancer-derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression. Int. J. Biol. Sci. 18, 1220–1237 (2022).
Google Scholar
Moreau, M. P. et al. Altered MicroRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatr. 69, 188–193 (2011).
Google Scholar
Poon, V. Y. et al. miR-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein Bmi1. BMC Genom. 17, 777 (2016).
Google Scholar
Li, H. et al. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. J. Hematol. Oncol. 11, 70 (2018).
Google Scholar
Zhuang, Z., Zhang, L. & Liu, C. SNHG14 upregulation was a molecular mechanism underlying MPP(+) neurotoxicity in dopaminergic SK-N-SH cells via SNHG14-miR-519a-3p-ATG10 ceRNA pathway. Neurotox. Res. 40, 553–563 (2022).
Google Scholar
Qiu, S. et al. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis. J. Exp. Clin. Cancer Res. 41, 296 (2022).
Google Scholar
Hong, S. et al. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment. Theranostics 11, 9687–9704 (2021).
Google Scholar
Jiang, D. et al. Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J. Nanobiotechnol. 18, 105 (2020).
Google Scholar
Li, Z. et al. M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic stroke in mice. Theranostics 11, 1232–1248 (2021).
Google Scholar
Ouyang, Q. et al. Brain-penetration and neuron-targeting DNA nanoflowers co-delivering miR-124 and rutin for synergistic therapy of Alzheimer’s disease. Small 18, e2107534 (2022).
Google Scholar
Esteves, M. et al. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson’s disease. Mol. Ther. 30, 3176–3192 (2022).
Google Scholar
Namkung, H. et al. The miR-124-AMPAR pathway connects polygenic risks with behavioral changes shared between schizophrenia and bipolar disorder. Neuron 111, 220–235.e229 (2023).
Google Scholar
Vermeire, S. et al. ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension. Lancet Gastroenterol. Hepatol. 7, 1024–1035 (2022).
Google Scholar
Ma, C. et al. miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression. Proc. Natl. Acad. Sci. USA 119, e2114006119 (2022).
Roser, A. E. et al. miR-182-5p and miR-183-5p act as GDNF mimics in dopaminergic midbrain neurons. Mol. Ther. Nucleic Acids 11, 9–22 (2018).
Google Scholar
Ding, W. et al. Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. Int. Immunopharmacol. 118, 110047 (2023).
Google Scholar
Soheilifar, M. H. et al. Concomitant overexpression of mir-182-5p and mir-182-3p raises the possibility of IL-17-producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: a meta-analysis and experimental study. Cancer Sci. 112, 589–603 (2021).
Google Scholar
Shu, L. et al. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Hepatology 79, 307–322 (2024).
Google Scholar
Rigg, E. et al. Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes. J. Extracell. Vesicles 12, e12363 (2023).
Google Scholar
Fan, C. et al. Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression. Mol. Ther. 30, 1300–1314 (2022).
Google Scholar
Kim, H. K. et al. Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment. J. Psychiatr. Res. 110, 38–44 (2019).
Google Scholar
Wu, C. S. et al. EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis. Cancer Cell Int. 23, 199 (2023).
Google Scholar
Yang, J. et al. MicroRNA-99a is a potential target for regulating hypothalamic synaptic plasticity in the peri/postmenopausal depression model. Cells. 8, 1081 (2019).
Hu, H. F. et al. The antipsychotic drug aripiprazole suppresses colorectal cancer by targeting LAMP2a to induce RNH1/miR-99a/mTOR-mediated autophagy and apoptosis. Adv. Sci. 11, e2409498 (2024).
Google Scholar
Yang, L. et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol. Cancer 18, 78 (2019).
Google Scholar
Zhao, J., Li, H. & Chang, N. LncRNA HOTAIR promotes MPP+-induced neuronal injury in Parkinson’s disease by regulating the miR-874-5p/ATG10 axis. Excli J. 19, 1141–1153 (2020).
Google Scholar
Zhang, Y. et al. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma. Cell Death Differ. 26, 2061–2073 (2019).
Google Scholar
Li, K. et al. Micro electrical fields induced MSC-sEVs attenuate neuronal cell apoptosis by activating autophagy via lncRNA MALAT1/miR-22-3p/SIRT1/AMPK axis in spinal cord injury. J. Nanobiotechnol. 21, 451 (2023).
Google Scholar
Lukowski, S. W. et al. A single-cell transcriptome atlas of the adult human retina. EMBO J. 38, e100811 (2019).
Google Scholar
Hussen, B. M. et al. A diagnostic panel for acquired immune-mediated polyneuropathies based on the expression of lncRNAs. Front. Immunol. 12, 643615 (2021).
Google Scholar
Malakar, P. et al. Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2. Cancer Res. 79, 2480–2493 (2019).
Google Scholar
Lu, C. et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol. Cancer 19, 28 (2020).
Google Scholar
Sun, Y. et al. In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer. J. Control Release 358, 142–160 (2023).
Google Scholar
Wan, P. et al. LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury. Cell Death Differ. 27, 176–191 (2020).
Google Scholar
Safari, M. R. et al. Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population. Gene 701, 121–124 (2019).
Google Scholar
Wen, S. et al. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol. Cancer 19, 171 (2020).
Google Scholar
Wang, C. et al. Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation. Mol. Cell 79, 443–458.e447 (2020).
Google Scholar
Park, M. K. et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 33, 2380–2397.e2389 (2021).
Google Scholar
Huang, X. et al. Engineered exosomes as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy. J. Control Release 343, 107–117 (2022).
Google Scholar
Balusu, S. et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science 381, 1176–1182 (2023).
Google Scholar
Bayarmaa, B. et al. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer. BMC Cancer 19, 877 (2019).
Google Scholar
Yan, H. et al. Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer. Int. J. Biol. Sci. 17, 2606–2621 (2021).
Google Scholar
